P-89: Type 1 diabetes TrialNet community partner engagement program (CPEP): design and early impact
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von C A March und 10 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Engaging community partners in research design and implementation is increasingly recommended. Data describing engagement in a type 1 diabetes (T1D) research consortium and its impact are limited.
Objectives
To characterize the development and early impact of CPEP, launched in 2025, for TrialNet, a multi-center network focused on T1D prevention.
Methods
CPEP recruited a community advisory board (CAB) via nominations from 18 centers in the US/Canada. CAB members had lived experience as a person/parent with stage 1-3 T1D and had participated in TrialNet (screening, monitoring, and/or clinical trials). Orientation included research ethics, expectations, and confidentiality. Activities included quarterly CAB meetings for large/small group discussion and options to join longitudinal protocol committees or attend steering committee meetings. Activities were virtual and compensated. CAB members’ experiences were assessed using a validated, semi-annual survey (PPEET).
Results
20 of 23 individuals recruited joined at least 1 meeting. CAB members (80% female, 30% identifying as a minority) had a personal/family history of stage 1-2 (60%) and/or stage 3 (75%) T1D. Quarterly meeting attendance averaged 15 members; 9 engaged in protocol committees and 6 in the steering committee. CAB members contributed to protocol and operational decisions, including: (1) reviewing prevention trial designs, (2) informing trial inclusion criteria, (3) augmenting recruitment materials and strategies, (4) altering participant survey items, and (5) recommending new approaches to incentivize participation. Year 1 survey responses indicated high overall satisfaction (Table). Comments highlighted co-learning, diversity, and respect.
Conclusions
Research consortium engagement is feasible and facilitates immediate and actionable feedback to investigators. Future work will measure impact on study efficiency, recruitment, and retention.
Zitieren
APA
March, C. A., Cameron, K., Dimeglio, L. A., Gaglia, J., Goland, R., Haller, M., Jacobsen, L., Sherr, J. L., Wherett, D. K., Herold, K., & Libman, I. (2026). P-89: Type 1 diabetes TrialNet community partner engagement program (CPEP): design and early impact. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.150
Vancouver
March CA, Cameron K, Dimeglio LA, Gaglia J, Goland R, Haller M, et al. P-89: Type 1 diabetes TrialNet community partner engagement program (CPEP): design and early impact. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.150
BibTeX
@article{March2026,
author = {March, C A and Cameron, K and Dimeglio, L A and Gaglia, J and Goland, R and Haller, M and Jacobsen, L and Sherr, J L and Wherett, D K and Herold, K and Libman, I},
title = {P-89: Type 1 diabetes TrialNet community partner engagement program (CPEP): design and early impact},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.150}
}
EUVIMED